A Brief Report of a Phase II trial Evaluating Efficacy and Safety of Hypomethylating Agent Guadecitabine in Combination With Carboplatin in Extensive Stage Small Cell Lung Cancer.
Saved in:
| Title: | A Brief Report of a Phase II trial Evaluating Efficacy and Safety of Hypomethylating Agent Guadecitabine in Combination With Carboplatin in Extensive Stage Small Cell Lung Cancer. |
|---|---|
| Authors: | Wei CX; Department of Hematology and Oncology, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN., Mamdani H; Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, MI., Gentzler R; Department of Hematology and Oncology, University of Virginia Cancer Center, UVA Health, Charlottesville, VA., Kalra M; LifeBridge Health, Alvin and Lois Lapidus Cancer Institute, Baltimore, MD., Perkins S; Department of Hematology and Oncology, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN., Althouse S; Department of Hematology and Oncology, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN., Jalal SI; Department of Hematology and Oncology, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN. Electronic address: sjalal@iu.edu. |
| Source: | Clinical lung cancer [Clin Lung Cancer] 2023 Jun; Vol. 24 (4), pp. 347-352. Date of Electronic Publication: 2023 Mar 21. |
| Publication Type: | Clinical Trial, Phase II; Research Support, Non-U.S. Gov't; Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37032265 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A Brief Report of a Phase II trial Evaluating Efficacy and Safety of Hypomethylating Agent Guadecitabine in Combination With Carboplatin in Extensive Stage Small Cell Lung Cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Wei+CX%22">Wei CX</searchLink>; Department of Hematology and Oncology, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN.<br /><searchLink fieldCode="AU" term="%22Mamdani+H%22">Mamdani H</searchLink>; Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, MI.<br /><searchLink fieldCode="AU" term="%22Gentzler+R%22">Gentzler R</searchLink>; Department of Hematology and Oncology, University of Virginia Cancer Center, UVA Health, Charlottesville, VA.<br /><searchLink fieldCode="AU" term="%22Kalra+M%22">Kalra M</searchLink>; LifeBridge Health, Alvin and Lois Lapidus Cancer Institute, Baltimore, MD.<br /><searchLink fieldCode="AU" term="%22Perkins+S%22">Perkins S</searchLink>; Department of Hematology and Oncology, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN.<br /><searchLink fieldCode="AU" term="%22Althouse+S%22">Althouse S</searchLink>; Department of Hematology and Oncology, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN.<br /><searchLink fieldCode="AU" term="%22Jalal+SI%22">Jalal SI</searchLink>; Department of Hematology and Oncology, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN. Electronic address: sjalal@iu.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100893225%22">Clinical lung cancer</searchLink> [Clin Lung Cancer] 2023 Jun; Vol. 24 (4), pp. 347-352. <i>Date of Electronic Publication: </i>2023 Mar 21. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase II; Research Support, Non-U.S. Gov't; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>100893225 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1938-0690 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215257304%22">15257304 </searchLink><i>NLM ISO Abbreviation: </i>Clin Lung Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37032265 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.cllc.2023.03.003 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 347 Titles: – TitleFull: A Brief Report of a Phase II trial Evaluating Efficacy and Safety of Hypomethylating Agent Guadecitabine in Combination With Carboplatin in Extensive Stage Small Cell Lung Cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Wei CX – PersonEntity: Name: NameFull: Mamdani H – PersonEntity: Name: NameFull: Gentzler R – PersonEntity: Name: NameFull: Kalra M – PersonEntity: Name: NameFull: Perkins S – PersonEntity: Name: NameFull: Althouse S – PersonEntity: Name: NameFull: Jalal SI IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2023 Jun Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1938-0690 Numbering: – Type: volume Value: 24 – Type: issue Value: 4 Titles: – TitleFull: Clinical lung cancer Type: main |
| ResultId | 1 |
